Back to Search Start Over

Suppl File from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....10ef00fe45b9ce87b96632e809265c98